NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Column
width20%
Table of Contents
maxLevel2

...

width80%

Module Status Table

...

CRF Modules

...

Round #

...

Current Status of Module

...

Adverse Events

...

2

...

Harmonization

...

Agent Study Administration

...

3

...

Internal Harmonization complete; Expanded Committee Review will follow Round 2.

...

Concomitant Medication Agents 

...

3

...

Internal Harmonization complete; Expanded Committee Review will follow Round 2.

...

Consent

...

4

...

Internal Harmonization complete; Expanded Committee Review will follow Round 3.

...

Demography

...

1

...

/

...

Diagnosis & Pathology

...

4

...

Internal Harmonization complete; Expanded Committee Review will follow Round 3.

...

Drug Accountability

...

3

...

Internal Harmonization complete; Expanded Committee Review will follow Round 2.

...

Eligibility Criteria

...

4

...

Internal Harmonization complete; Expanded Committee Review will follow Round 3.

...

End of Form

...

4

...

Internal Harmonization complete; Expanded Committee Review will follow Round 3.

...

Enrollment

...

2

...

Internal Harmonization complete; Expanded Committee Review in session.

...

Footer

...

4

...

Internal Harmonization complete; Expanded Committee Review will follow Round 3.

...

Header Information

...

4

...

Internal Harmonization complete; Expanded Committee Review will follow Round 3.

...

Imaging & Radiology

...

4

...

Internal Harmonization currently underway.

...

Laboratory Tests & Results

...

3

...

Internal Harmonization complete; Expanded Committee Review will follow Round 2.

...

Medical History

...

2

...

Internal Harmonization complete; Expanded Committee Review in session.

...

Non-Agent Study Interventions

...

4

...

Internal Harmonization complete; Expanded Committee Review will follow Round 3.

...

Off Treatment_Off Study

...

4

...

Internal Harmonization complete; Expanded Committee Review will follow Round 3.

...

Outcome Measures

...

3

...

Internal Harmonization complete; Expanded Committee Review will follow Round 2.

...

Participant Identifier

...

2

...

Internal Harmonization complete; Expanded Committee Review in session.

...

Physical Exams

...

2

...

Internal Harmonization complete; Expanded Committee Review in session.

...

Pre & Post Treatment Agents 

...

3

...

Internal Harmonization complete; Expanded Committee Review will follow Round 2.

...

Protocol Deviations

...

2

...

Internal Harmonization complete; Expanded Committee Review in session.

...

Registrations

...

2

...

Internal Harmonization complete; Expanded Committee Review in session.

...

Screening

...

4

...

Internal Harmonization complete; Expanded Committee Review will follow Round 3.

...

Staging & Extent of Disease

...

3

...

Internal Harmonization complete; Expanded Committee Review will follow Round 2.

...

Vital Signs

...

4

...

Internal Harmonization complete; Expanded Committee Review will follow Round 3.

Introduction

The Standardized Case Report Form (CRF) Work Group is focused on establishing a core library of harmonized and standardized Phase II and III CRFs and data collection modules through stakeholder consensus. A core library of harmonized and standardized CRFs will be highly valuable to the cancer clinical trials community because it will provide a standardized mechanism for comparing and aggregating information across the NCI's clinical trial portfolio. Additionally, a harmonized CRF library will improve the efficiency and accuracy of the routine review of safety, efficacy, and administrative data from ongoing NCI-funded clinical trials. Finally, by reducing the time spent in developing a data collection strategy per trial, this core library will allow for faster initiation of new trials; thus, speeding the process of delivering new and improved treatments to patients.

The Standardized CRF Work Group is part of the Study Conduct Special Interest Group (SIG) and the Clinical Trials Management Systems (CTMS) Workspace.

...

Standardization Process 

The CRF Harmonization and Standardization initiative has undertaken the task of harmonizing and standardizing case report forms for cancer clinical trials by first dissecting the CRF into modules and tackling smaller sections of the CRF 5 areas at a time.

...

The general process includes collecting an inventory of forms related to the information generally captured in that module, for example, On-Study Forms are

...

collected to gather Agent information.

...

The group then goes through all the forms and identifies those fields that are relevant to that module (area), partitions the fields as either Mandatory, Conditional or Optional, and then identifies appropriate Common Data Elements (CDEs) or creates new CDEs to accurately capture the metadata for the harmonized fields.

...

Once the group identifies all the fields and CDEs to be collected in that module, these are sent to the Clinical Trials Community for review and comment, the comments are addressed, and the final list of fields are presented to the Clinical & Translational Research Operating Committee (CTROC) for final approval.

...

After CTROC approval, the CDEs are brought to the Vocabularies & Common Data Elements (VCDE) Workspace for review as caBIG Standards.

...

Once the CDEs are made standard, the module is officially available for use on cancer clinical trials.

In October of 2009, the need for an Expanded Committee Review was identified.  A change in the community review process was instituted in the Spring of 2010.

...

The revised process is as follows:

1

NCI CBIIT staff create CRF inventory

2

Working group aggregates and identifies key content, resolves discrepancies, harmonizes - expansion in working group membership to include named point of contacts (POCs) for all major internal and external clinical trial stakeholders

3

Working group partitions content - mandatory, conditional, optional

4

Working group achieves consensus on final list of elements, assures adherence to data standards

5

Executive summary sent to Clinical and Translational Research Operations Committee (CTROC)

6

Module circulated for broad community review

7

Working group reviews and responds to changes from community review  - POCs for all major internal and external clinical trial stakeholders provide formal approval of CRF elements prior to subsequent review

8

CRF Subcommittee of the CTMS Steering Committee reviews and approves - newly formed subcommittee ensures review by critical external clinical trial stakeholders, e.g., NCI cooperative groups

9

CTROC reviews and approves

10

Annual review cycle

...

CRF Standardization Process diagramImage Added

Status of CRF Activities

The first Round of the CRF Harmonization

...

and Standardization Project addressed a single module, Demography.

...

This work began in June 2007, and the module has gone through the the entire process and has been approved by CTROC, and the CDEs have been made standard.

...

The module is undergoing implementation/deployment for use in cancer clinical trials.

Round 2 included Adverse Events, Baseline Assessment, Participant Identification, Registration & Enrollment, and Protocol Deviations.

...

Seven modules were completed from those 5 areas, which are Adverse Events, Medical History, Physical Exam, Participant Identification, Registration, Enrollment, and Protocol Deviations.

...

These seven modules have been vetted by the Community and approved by CTROC

...

. In the spring of 2010 the seven modules entered expanded community review. Community review completed three rounds of evaluation through 2010 and in March of 2011 was forwarded to NCI leadership for finalization.

Round 3 modules

...

included Agents (looking at both standardizing vocabulary and the variables to be collected), End of Form, Footer, Header, Laboratory Tests/Results, Outcome Measures, and Staging/Extent of Disease.

...

These modules

...

were reviewed by the Community, presented to CTROC, and

...

finalized in April of 2011.

The Round 4 modules

...

included Consent, Diagnosis (Administrative), Diagnosis (Intervention), Eligibility, Equipment, Image Quality, Off Study, Off Treatment, PET Scan, PET Equipment QC, PET Imaging Agent, PET Patient Prep, Radiation Therapy, Screening, Surgery and Vital Signs were reviewed by and approved by NCI representatives in May 2013 and all modifications were completed and released in September.

Round 5 modules included CT Image Acquisition, CT Image Agent, Diagnosis Gross Pathology, Diagnosis Metastasis, Diagnosis Microscopic Pathology, Diagnosis, Survival/Follow-up, Image Administration, Lost to Follow-up, Progression, Response and RECIST.  A final review of the Round 5 content was completed in early 2018.  With the exception of the RECIST form, all other forms were finalized and released in June 2018.  The RECIST working group has additional comments regarding this content and will make recommendations for updates. 

Module Status Table

** Modules are alphabetized

** Content that is marked Final is ready for use.  Content that is marked Under Review is candidate status and is available to use but please note that this content could change in the final release.

CRF Modules

Round #

Status

Status Description

Adverse Events

2

Final

Total of 29 CDEs built in three CRF standard modules – CTCAE v3.0 reporting requirements, CTCAE v4.0 reporting requirements and CTCAE v5.0 reporting requirements. AE modules include Serious Adverse Event (SAE) CDEs.

Base Interventions

3

Not Needed - Removed

The intent of the Base Interventions module was to group all commonly-used CDEs need for primarily intervention studies.  In one module CDEs for start date, stop date, dose, Unit of measure, dose, etc., were grouped.  Reviewers did not feel this was the best way to categorize the elements.  So the pertinent elements in the Base Interventions module were instead added to each intervention/agent module.  The Base Interventions module is retired, and not part of the final Standard CRF set.

Concomitant Medication

3

Final

Total of 13 CDEs built in one CRF standard module.

Consent

4

FinalTotal of 6 CDEs built in one CRF standard module.
CT Image Acquisition5FinalTotal of 19 CDEs built in one CRF standard module.
CT Imaging Agent5FinalTotal of 19 CDEs built in one CRF standard module.

Demography

1

Final

Total of 15 CDEs built in one CRF standard module.

Diagnosis (Administrative)

4

Final

Total of 7 CDEs built in one CRF standard module.

Diagnosis (Intervention)

4

Final

Total of 6 CDEs built in one CRF standard module.
Diagnosis5FinalTotal of 14 CDEs built in one CRF standard module.
Diagnosis Gross Pathology5FinalTotal of 19 CDEs built in one CRF standard module.
Diagnosis Metastasis5FinalTotal of 4 CDEs built in one CRF standard module.
Diagnosis Microscopic Pathology5FinalTotal of 19 CDEs built in one CRF standard module.

Drug Compliance

3

Not Needed - Removed

Review demonstrated that 5 of the 8 CDEs in this module are repeated in the Study Administration CRF module.  So the remaining 3 CDEs were merged with the Study Administration CRF standard module, and the Drug Compliance module removed as a separate CRF module.

Eligibility

4

Final

Total of 9 CDEs built in one CRF standard module.

End of Form

3

Final

Total of 8 CDEs built in one CRF standard module.

Enrollment

2

Final

Total of 5 CDEs built in one CRF standard module.

Equipment

4

Final

Total of 10 CDEs built in one CRF standard module.
Follow-Up5Not Needed - Combined with Survival 
Follow-Up/Survival5FinalTotal of 18 CDEs built in one CRF standard module.

Footer

3

Final

Total of 5 CDEs built in one CRF standard module.

Header

3

Final

Total of 11 CDEs built in one CRF standard module.
Image Administration5FinalTotal of 17 CDEs built in one CRF standard module.

Image Quality

4

Final

Total of 7 CDEs built in one CRF standard module.

Laboratory Tests and Results

3

Final

Total of 14 CDEs built in one CRF standard module.
Lost to Follow-up5FinalTotal of 7 CDEs built in one CRF standard module.

Medical History

2

Final

Total of 7 CDEs built in one CRF standard module.

Outcome Measures

3

Not Needed - Removed

The outcome module was created in round 2.  At the time of delivery the limitations in the content were recognized, and we had a plan to expand the content at some point and also look mainly at response results in nonsolid tumors, like the leukemias and lymphomas.  So round 5 was envisioned as expanding two main areas in round 2 – 1) responses had to be expanded beyond the solid tumors, and 2) survival had to be expanded.  Therefore, Outcomes in round 2 have now been replaced by content in round 5.  

Off Study

4

Final

Total of 3 CDEs built in one CRF standard module.

Off Treatment

4

FinalTotal of 3 CDEs built in one CRF standard module.

Participant Identification

2

Final

Total of 11 CDEs built in one CRF standard module.

PET Emissions Scan

4

Final

Total of 12 CDEs built in one CRF standard module.

PET Equipment QC Assessment

4

Final

Total of 2 CDEs built in one CRF standard module.

PET Imaging Agent

4

Final

Total of 22 CDEs built in one CRF standard module.

PET Patient Prep

4

Final

Total of 7 CDEs built in one CRF standard module.
Progression5FinalTotal of 8 CDEs built in one CRF standard module.

Physical Examination

2

Final

Total of 6 CDEs built in one CRF standard module.

Prior/Post Therapy Agents

3

Final

Total of 17 CDEs built in one CRF standard module.

Protocol Deviations

2

Final

Total of 8 CDEs built in one CRF standard module. The use of a Protocol Deviation module is NOT recommended. Deviation data should be recorded in the appropriate form (agent administration, AE, etc.). However, if a sponsor mandates the use of an additional Protocol Deviation module, the identified variables should be used.

Radiation Therapy

4

Final

Total of 31 CDEs built in one CRF standard module.
RECIST5Under Review 

Registration

2

Final

Total of 19 CDEs built in one CRF standard module.
Response5FinalTotal of 31 CDEs built in one CRF standard module.

Screening

4

Final

Total of 4 CDEs built in one CRF standard module.

Staging/Extent of Disease

3

Final

Total of 28 separate CRF modules for major disease groups, including Leukemia, Lymphoma, and Solid tumors. There is no generic stage CRF module content. All CRF modules begin with ‘Staging’ and then have the specific diagnostic group. CDEs in these modules are largely but not exclusively based on AJCC edition 7.0 collaborative staging criteria.

Study Agent Administration

3

Final

Total of 21 CDEs built in one CRF standard module.

Surgery

4

Final

Total of 31 CDEs built in one CRF standard module.
Survival5Not Needed - Combined with Follow Up 

Vital Signs

4

Final

Total of 24 CDEs built in one CRF standard module.

Metrics

The CRF Harmonization & Standardization project was initiated to provide a harmonized and standardized set of variables to be collected for oncology clinical trials that could be implemented to facilitate data entry, and study aggregation, comparison and analysis. The CRF collection process for Rounds 1-3 only collected Case Report Forms specific for that module. However, prior to Round 4, the Workgroup Leads recommended collecting CRFs for all areas and doing a single CRF inventory for all remaining modules, current and future Rounds

...

The general metrics from the Round 4 CRF Inventory include:

17 Contributing Organizations
Contributing Organizations: CCR, DCP, University of Pennsylvania, CDASH, NCCTG, CTMS Theradex, CIP (FIMSO), UCSD, CALGB, COH, ACOSOG, Duke, ACRIN, ECOG, University of Michigan, Baylor College of Medicine, and RTOG
237 Case Report Forms
7697 variables (total)
More metrics on the CRFs, variables and modules will be posted on this page and the Metrics Child Page: https://wiki.nci.nih.gov/display/CTMS/CRF+Project+Metrics

...

 

CRF Project Wiki Child Pages

Children Display

Section
Panel
titleContents of this Page

Table of Contents
minLevel2

Include Page
CRF Quick Links
CRF Quick Links